Recent Press Releases

Celltrion and Medidata Team Up to Transform Global Clinical Trials for Biosimilars

NEW YORK & SEOUL, Korea--()--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, and Korean biopharmaceutical...

Catalent To Open New Clinical Supply Facility In Japan

Somerset, N.J., — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global...

PAREXEL Announces Execution of Definitive Agreement to Acquire Health Advances

Acquisition will strengthen PAREXEL's Leadership in Strategic Consulting Services BOSTON, January 19, 2016 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global...

Leading Provider Expands into Financial Management Solutions for Clinical Trials

Bioclinica®, Inc., a specialty clinical trials services and technology provider, announced today that it has acquired Clinverse, Inc. The acquisition expands Bioclinica's offerings into the...

New Clinic in Miami Extends inVentiv Health Phase I Services to the U.S.

MIAMI, Jan. 12, 2016 /PRNewswire/ -- inVentiv Health, a top-tier professional services organization that accelerates the clinical and commercial success of biopharmaceutical companies worldwide,...

Evotec Achieves Important Milestone in TargetAD Collaboration with Janssen in Alzheimer's Disease

HAMBURG, Germany--()--Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced the achievement of an important milestone in its TargetAD collaboration with...

Eurofins reinforces its market leadership in pharmaceutical products testing with the acquisition of Sinensis Life Sciences B.V.

Eurofins Scientific (EUFI.PA), the world leader in pharmaceutical products testing, announces the acquisition of Sinensis Life Sciences B.V. ("Sinensis"), the leading provider of...

AMRI ANNOUNCES 3-YEAR EXTENSION OF INSOURCING CONTRACT

ALBANY, N.Y., Jan. 12, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) is pleased to announce the extension of a key insourcing relationship with a major pharmaceutical company designed to accelerate their...

EAGLE PHARMACEUTICALS AND AMRI ANNOUNCE AGREEMENT TO JOINTLY DEVELOP, MANUFACTURE AND COMMERCIALIZE PARENTERAL DRUG PRODUCTS

WOODCLIFF LAKE, N.J. & ALBANY, N.Y.--(BUSINESS WIRE)-- Eagle Pharmaceuticals ("Eagle" or the "Company") (NASDAQ:EGRX) and AMRI (NASDAQ:AMRI) today announced that they have...

AMRI AND NYCNMR FORM COLLABORATIVE AGREEMENT

COLLABORATION TO ENHANCE APPLICATION OF NANOTECHNOLOGY IN INTEGRATED DRUG DISCOVERY SETTING BUFFALO, N.Y., Jan. 14, 2016 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced...

Catalent Biologics Announces Research Collaboration with Roche on SMARTag™ Technology

SOMERSET, N.J.--()--Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products...

BioDuro, LLC Adds Industry Veteran CFO To Executive Team

SAN DIEGO, Jan. 7, 2016 /PRNewswire/ -- BioDuro, LLC, a global CRO leader focused on preclinical chemistry, biology, and fully outsourced integrated drug development services for pharmaceutical...

Algorithme Pharma, Vince & Associates Clinical Research and Algorithme Pharma USA's New Look

LAVAL, Quebec--()--Altasciences Clinical Research's companies Algorithme Pharma, Vince & Associates Clinical Research and Algorithme Pharma USA announced today that they are...

Evotec and UCB sign multi-year sample management agreement

Hamburg, Germany - 07 January 2016: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced an EVT Execute collaboration aimed at providing a complete solution to...

Charles River Laboratories to Acquire WIL Research

– Enhances Charles River's Position as a Leading Global Early-Stage CRO – – Transaction Expected to be Accretive to Non-GAAP EPS by At Least $0.20 in 2016 and$0.45-$0.50 in 2017...

X-Chem Established as Independent, Privately Owned Biotechnology Company

WALTHAM, Mass.--()--X-Chem announced today that it has been spun out to the shareholders of the parent company of Pharmaceutical Product Development, LLC ("PPD") as an...

Porsolt Expands Its in Vitro Drug Discovery Service Capabilities With the Acquisition of Fluofarma

Porsolt has acquired Fluofarma, a Bordeaux-based company focused on the provision of cell-based assays and in vitro screening services. The acquisition further expands Porsolt's capabilities and...

QPharma Announces Acquisition of Qforma

Life Sciences Leader Will Expand, Enhance Solution Offerings QPharma, a premier provider of compliance and commercial services to the life sciences industry, has announced the acquisition of...

PDI Completes Sale of Its Commercial Services Business to Publicis Healthcare Communications Group

PARSIPPANY, N.J., Dec. 22, 2015 /PRNewswire/ -- PDI, Inc. (PDII) announced the closing of the definitive asset purchase agreement under which Publicis Healthcare Communications Group has acquired...

PDI, Inc. Implements Leadership Transition

PARSIPPANY, N.J., Dec. 22, 2015 /PRNewswire/ -- PDI, Inc.(PDII) today reported that as the Company transitions to focusing solely on its molecular diagnostics operations, Nancy Lurker has resigned as...